Text Registration
Copyright Title
The Pharmagellan Guide to Biotech Forecasting & Valuation
Status
Published
on 4 Jan 2017
Year of Creation
2016
Copyright Claimant
Pharmagellan, LLC
Registration Number
TX0008353811
on 4 Jan 2017Copyright Summary
The U.S. Copyright record (Registration Number: TX0008353811) dated 4 Jan 2017, pertains to an electronic file (eService) titled "The Pharmagellan Guide to Biotech Forecasting & Valuation" created in 2016. The copyright holder is Pharmagellan, LLC, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Pharmagellan, LLC.
Application Details
Registration Number
TX0008353811
Registration Date
1/4/2017
Year of Creation
2016
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Pharmagellan, LLC
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Frank S. David, Pharmagellan, LLC, 80 William Street, Suite 200, Wellesley, MA, 02481, United States, (617) 291-9934, frank@pharmagellan.com
Statements
Application Title Statement: The Pharmagellan Guide to Biotech Forecasting & Valuation
Author Statement: Frank S. David 1971 Domicile: United States Citizenship: United States Authorship: text Pharmagellan, LLC employer for hire Citizenship: United States Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.